Summary

Food Allergy Market – Scope of Report
TMR’s report on the global food allergy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global food allergy market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global food allergy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the food allergy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global food allergy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global food allergy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global food allergy market.

The report delves into the competitive landscape of the global food allergy market. Key players operating in the global food allergy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global food allergy market profiled in this report.

Key Questions Answered in Global food allergy Market Report
• What is the sales/revenue generated by food allergy across all regions during the forecast period?
• What are the opportunities in the global food allergy market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Food Allergy Market – Research Objectives and Research Approach
The comprehensive report on the global food allergy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global food allergy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global food allergy market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Food Allergy Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Food Allergy Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Food Allergy Market Analysis and Forecast, by Food Source
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Food Source, 2020-2034
6.3.1. Dairy Products
6.3.2. Poultry Products
6.3.3. Tree Nuts
6.3.4. Peanuts
6.3.5. Shellfish
6.3.6. Wheat
6.3.7. Others (Soy, etc.)
6.4. Market Attractiveness, by Food Source
7. Global Food Allergy Market Analysis and Forecast, by Diagnosis
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Diagnosis, 2020-2034
7.3.1. Skin-prick Tests
7.3.2. Blood Test
7.3.3. Elimination Diet
7.3.4. Others (Oral Food Challenge, etc.)
7.4. Market Attractiveness, by Diagnosis
8. Global Food Allergy Market Analysis and Forecast, by Treatment Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Treatment Type, 2020-2034
8.3.1. Epinephrine
8.3.2. Antihistamines
8.3.3. Oral Immunotherapy
8.3.4. Others (Adrenaline, etc.)
8.4. Market Attractiveness, by Treatment Type
9. Global Food Allergy Market Analysis and Forecast, by Distribution Channel
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Distribution Channel, 2020-2034
9.3.1. Hospital Pharmacy
9.3.2. Retail Pharmacy
9.3.3. Online Pharmacy
9.4. Market Attractiveness, by Distribution Channel
10. Global Food Allergy Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Food Allergy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Food Source, 2020-2034
11.2.1. Dairy Products
11.2.2. Poultry Products
11.2.3. Tree Nuts
11.2.4. Peanuts
11.2.5. Shellfish
11.2.6. Wheat
11.2.7. Others (Soy, etc.)
11.3. Market Attractiveness, by Food Source
11.4. Market Value Forecast, by Diagnosis, 2020-2034
11.4.1. Skin-prick Tests
11.4.2. Blood Test
11.4.3. Elimination Diet
11.4.4. Others (Oral Food Challenge, etc.)
11.5. Market Attractiveness, by Diagnosis
11.6. Market Value Forecast, by Treatment Type, 2020-2034
11.6.1. Epinephrine
11.6.2. Antihistamines
11.6.3. Oral Immunotherapy
11.6.4. Others (Adrenaline, etc.)
11.7. Market Value Forecast, by Distribution Channel, 2020-2034
11.7.1. Hospital Pharmacy
11.7.2. Retail Pharmacy
11.7.3. Online Pharmacy
11.8. Market Attractiveness, by Distribution Channel
11.9. Market Value Forecast, by Country/Sub-region, 2020-2034
11.9.1. U.S.
11.9.2. Canada
11.10. Market Attractiveness Analysis
11.10.1. By Food Source
11.10.2. By Diagnosis
11.10.3. By Treatment Type
11.10.4. By Distribution Channel
11.10.5. By Country
12. Europe Food Allergy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Food Source, 2020-2034
12.2.1. Dairy Products
12.2.2. Poultry Products
12.2.3. Tree Nuts
12.2.4. Peanuts
12.2.5. Shellfish
12.2.6. Wheat
12.2.7. Others (Soy, etc.)
12.3. Market Attractiveness, by Food Source
12.4. Market Value Forecast, by Diagnosis, 2020-2034
12.4.1. Skin-prick Tests
12.4.2. Blood Test
12.4.3. Elimination Diet
12.4.4. Others (Oral Food Challenge, etc.)
12.5. Market Attractiveness, by Diagnosis
12.6. Market Value Forecast, by Treatment Type, 2020-2034
12.6.1. Epinephrine
12.6.2. Antihistamines
12.6.3. Oral Immunotherapy
12.6.4. Others (Adrenaline, etc.)
12.7. Market Attractiveness, by Treatment Type
12.8. Market Value Forecast, by Distribution Channel, 2020-2034
12.8.1. Hospital Pharmacy
12.8.2. Retail Pharmacy
12.8.3. Online Pharmacy
12.9. Market Attractiveness, by Distribution Channel
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Food Source
12.11.2. By Diagnosis
12.11.3. By Treatment Type
12.11.4. By Distribution Channel
12.11.5. By Country/Sub-region
13. Asia Pacific Food Allergy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Food Source, 2020-2034
13.2.1. Dairy Products
13.2.2. Poultry Products
13.2.3. Tree Nuts
13.2.4. Peanuts
13.2.5. Shellfish
13.2.6. Wheat
13.2.7. Others (Soy, etc.)
13.3. Market Attractiveness, by Food Source
13.4. Market Value Forecast, by Diagnosis, 2020-2034
13.4.1. Skin-prick Tests
13.4.2. Blood Test
13.4.3. Elimination Diet
13.4.4. Others (Oral Food Challenge, etc.)
13.5. Market Attractiveness, by Diagnosis
13.6. Market Value Forecast, by Treatment Type, 2020-2034
13.6.1. Epinephrine
13.6.2. Antihistamines
13.6.3. Oral Immunotherapy
13.6.4. Others (Adrenaline, etc.)
13.7. Market Attractiveness, by Treatment Type
13.8. Market Value Forecast, by Distribution Channel, 2020-2034
13.8.1. Hospital Pharmacy
13.8.2. Retail Pharmacy
13.8.3. Online Pharmacy
13.9. Market Attractiveness, by Distribution Channel
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Food Source
13.11.2. By Diagnosis
13.11.3. By Treatment Type
13.11.4. By Distribution Channel
13.11.5. By Country/Sub-region
14. Latin America Food Allergy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Food Source, 2020-2034
14.2.1. Dairy Products
14.2.2. Poultry Products
14.2.3. Tree Nuts
14.2.4. Peanuts
14.2.5. Shellfish
14.2.6. Wheat
14.2.7. Others (Soy, etc.)
14.3. Market Attractiveness, by Food Source
14.4. Market Value Forecast, by Diagnosis, 2020-2034
14.4.1. Skin-prick Tests
14.4.2. Blood Test
14.4.3. Elimination Diet
14.4.4. Others (Oral Food Challenge, etc.)
14.5. Market Attractiveness, by Diagnosis
14.6. Market Value Forecast, by Treatment Type, 2020-2034
14.6.1. Epinephrine
14.6.2. Antihistamines
14.6.3. Oral Immunotherapy
14.6.4. Others (Adrenaline, etc.)
14.7. Market Attractiveness, by Treatment Type
14.8. Market Value Forecast, by Distribution Channel, 2020-2034
14.8.1. Hospital Pharmacy
14.8.2. Retail Pharmacy
14.8.3. Online Pharmacy
14.9. Market Attractiveness, by Distribution Channel
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Food Source
14.11.2. By Diagnosis
14.11.3. By Treatment Type
14.11.4. By Distribution Channel
14.11.5. By Country/Sub-region
15. Middle East & Africa Food Allergy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Food Source, 2020-2034
15.2.1. Dairy Products
15.2.2. Poultry Products
15.2.3. Tree Nuts
15.2.4. Peanuts
15.2.5. Shellfish
15.2.6. Wheat
15.2.7. Others (Soy, etc.)
15.3. Market Attractiveness, by Food Source
15.4. Market Value Forecast, by Diagnosis, 2020-2034
15.4.1. Skin-prick Tests
15.4.2. Blood Test
15.4.3. Elimination Diet
15.4.4. Others (Oral Food Challenge, etc.)
15.5. Market Attractiveness, by Diagnosis
15.6. Market Value Forecast, by Treatment Type, 2020-2034
15.6.1. Epinephrine
15.6.2. Antihistamines
15.6.3. Oral Immunotherapy
15.6.4. Others (Adrenaline, etc.)
15.7. Market Attractiveness, by Treatment Type
15.8. Market Value Forecast, by Distribution Channel, 2020-2034
15.8.1. Hospital Pharmacy
15.8.2. Retail Pharmacy
15.8.3. Online Pharmacy
15.9. Market Attractiveness, by Distribution Channel
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Food Source
15.11.2. By Diagnosis
15.11.3. By Treatment Type
15.11.4. By Distribution Channel
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Akorn Operating Company LLC
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Pfizer Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. GSK plc
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Novartis AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Mylan N.V.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Sanofi S.A.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Boehringer Ingelheim
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. AstraZeneca plc
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Bayer AG
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Merck & Co., Inc.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. F. Hoffmann-La Roche Ltd.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview